![]() | Only 14 pages are availabe for public view |
Abstract Summary Atrial fibrillation is a supraventricular arrhythmia characterized by disorganized atrial depolarisations without effective atrial contractions. It occurs in patients with cardiac disorders as well as in patients with no apparent cardiac abnormalities (lone AF). It is due to an abnormality of the electrical signalling pathway .Therapeutic options in AF include unstable patients requiring immediate DC cardioversion, rhythm control and rate control for AF. Every patient with AF should be evaluated for the need of antithrombotic therapy to prevent systemic embolization. Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. Thromboembolism is the combination of thrombosis and its main complication, embolism . The most common cause of arterial occlusion is atrial fibrillation, which causes a blood stasis within the atria with easy thrombus formation. On the other hand, cardiomyopathy refers to diseases of the heart muscle. The main types of cardiomyopathy are: dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy and arrhythmogenic right ventricular dysplasia. Hypertrophic cardiomyopathy occurs if heart muscle cells enlarge and cause the walls of the ventricles (usually the left ventricle) to thicken. In patients with hypertrophic cardiomyopathy, atrial fibrillation is the most common clinical complication, with a prevalence exceeding 20%. The occurrence of AF represents a turning point in the clinical course of the disease, in which it is generally associated with deterioration of clinical status, functional capacity, quality of life, and long-term outcome .The mechanisms that predispose HCM patients to develop AF are variable and include genetic factors, structural abnormalities, as well as prolonged and impaired atrial conduction due to atrial myopathy. Predictors of AF in HCM include left atrial diameter, volume and function, age, and NYHA class. Systemic embolic events and stroke are known to occur as complications of HCM. The profound complications of HCM, which may lead to disability and death, were substantially more common in the elderly, occurred almost exclusively in patients with paroxysmal or chronic atrial fibrillation and appeared to be reduced in frequency by anticoagulation. |